Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DEA-Mandated Opioid Training Allows Dispensing To Be Unencumbered By REMS

Executive Summary

The prescriber education mandate envisioned as part of the Obama administration’s plan to curb prescription drug abuse could plunge the Drug Enforcement Administration into unfamiliar territory, although the agency seems eager to stay away from it.

You may also be interested in...



Mandatory Training For Opioid Prescribers Remains Stuck On Drawing Board

FDA and DEA continued to negotiate through the Office of National Drug Control Policy on a viable option for a mandatory prescriber education program, which would be a large burden for whichever agency gets the job.

Opioid Prescriber Education Mandate Could Be Added To User Fee Bill

Sen. Rockefeller introduces amendment that would require 16 hours of training every three years to maintain DEA registration.

Pain Prescriber Education Programs Need Better Coordination, GAO Says

FDA and other federal agencies could better coordinate their efforts to educate prescribers about prescription pain reliever abuse, the Government Accountability Office said.

Related Content

Topics

UsernamePublicRestriction

Register

PS053347

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel